Swiss researchers create artificial lung to study Covid-19 blood clots
A Belgian doctor studies an x-ray of the lungs of a patient who is suspected of having Covid-19, March 24, 2020
Keystone / Stephanie Lecocq
Scientists at the Federal Institute of Technology Lausanne (EPFL) have created an artificial lung to better understand how the new coronavirus causes blood clots in certain patients.
This content was published on
3 minutes
EPFL/sb
Português
pt
Pesquisadores suíços criam pulmão artificial para estudar coágulos de sangue de Covid-19
A recent studyExternal link revealed that around 10% of hospitalised Covid-19 patients develop blood clots, however, it is unclear why the virus causes this reaction. In the most severe cases, the blood clots can result in a stroke.
To investigate this phenomenon and other Covid-19 infections, EPFL scientists have developed a microfluidic chip that models the human lung and replicates part of its structure.
The chip holds lung epithelial cells, blood-vessel cells and immune-system cells, and lets scientists directly observe how the virus attacks human cells and triggers the formation of blood clots.
When that happens, scientists say two mechanisms may be occurring. One is an excess production of cytokines, which are proteins that play a role in immune-cell signalling, leading to so-called “cytokine storms”. These can damage blood vessels and cause blood clots to form, and are potentially fatal.
The other possible reason is damage to the interior lining of blood vessels – or the endothelium – in the lungs. The lungs have a lot of this kind of tissue, and when it’s damaged, blood can coagulate easily and form clots.
Lung-on-a-chip
To help find out, the EPFL team took a lung-on-a-chip device and adapted it to model the individual steps in a SARS-CoV-2 attack on the lungs. The device contains microfluidic channels that feed nutrients to cells on the chip, which are arranged to recreate a section of the lungs.
Inside the chip there is a layer of epithelial cells, the cells coating the lungs, and a layer of endothelial cells, the cells lining the blood vessels. These two layers are separated by a membrane.
During their tests, when the virus was introduced into their device it first attacked the outside layer of epithelial cells, just like in a natural infection. The team found that within a day the virus had reached the inner layer of endothelial cells and caused considerable damage over subsequent days.
“There was enough damage to destroy the endothelium and expose blood in the vessels to air, causing clots to form,” says Vivek Thacker, a postdoctoral researcher. “With our lung-on-a-chip system, we found that the virus may be causing blood clots by attacking the endothelium directly. However, that doesn’t mean that cytokines don’t play a role too and make things worse.”
To further their understanding, the team plan to use their lung-on-a-chip with actual blood samples so that they can observe clot formation directly.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Zurich laboratory finds intestinal bacteria in coffee machines
This content was published on
Last year, the Zurich Cantonal Laboratory found defects in one in four samples of milk drinks from coffee machines. Too many intestinal bacteria were found in a number of samples.
SWISS Belgrade-Zurich flight forced to land in Germany
This content was published on
Swiss flight LX1413 from Belgrade to Zurich had to make an unscheduled landing today in Friedrichshafen, southern Germany.
New Swiss 3D simulation tool offers better landslide forecasting
This content was published on
A new 3D simulation tool is enabling much more accurate avalanche forecasts. The model, which proved its worth during the landslides in Brienz (GR) and Blatten (VS), could lead to more effective management of alpine risks.
Alleged leader of Kosovar terrorist group indicted in Switzerland
This content was published on
The Office of the Attorney General of Switzerland has brought charges against a Kosovar on suspicion of being the leader of the Swiss branch of a Kosovar terrorist organisation. He is also suspected of having been active in the management of the organisation in Kosovo.
Swiss glacier lake drains without causing flooding damage
This content was published on
The Faverges glacial lake on the Plaine Morte above Lenk in the Bernese Oberland drained over the weekend. There was no flooding or damage, the authorities announced on Monday.
Chihuahua leads Swiss rescue team to owner stuck in a crevasse
This content was published on
A Chihuahua helped to rescue a man on the Fee Glacier above Saas-Fee VS on Friday. It alerted a rescue team to its owner who had fallen into a crevasse.
Swiss bosses distance themselves from the United States
This content was published on
According to a survey of managers, Swiss companies are increasingly turning away from the USA and orientating themselves more towards Southeast Asia and the EU. This is the result of a recent survey.
This content was published on
The Fête de l'Epouvantail (scarecrow festival) is celebrating its 30th anniversary and returns to Denens in canton Vaud for its seventh edition from July 10-20.
Swiss factory rushes to prepare for Moderna Covid-19 vaccine
This content was published on
Workers are racing to set up production lines at the Lonza factory in Visp to be able to start making a vaccine for US firm Moderna later this year.
Virologist calls for more tests, masks for children
This content was published on
Geneva virologist Isabella Eckerle has called for more testing and obligatory mask wearing for younger children at school.
Lausanne hospital test chosen for coronavirus study
This content was published on
A test developed at Lausanne university hospital has been chosen for wide-scale coronavirus antibody studies of the Swiss population.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.